Clinical trial

Cell Therapy for Diabetic Foot Ulcer

NCT05234086

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2020-01-02

PhasePHASE2

Study timeline

Study start (actual)2020-01-02Date precision: day

Registry last updated2022-02-10

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetic Foot Ulcer Associated With Type II Diabetes Mellitusunresolved

Wound Healunresolved

Interventions

InbioDerm + C plus advanced healingCOMBINATION_PRODUCT

Advanced healingPROCEDURE

Sponsors & collaborators

Instituto para el Desarrollo Biotecnológico y la Innovación S.A.lead sponsor

Corporación de Fomento de la Producción, Chilecollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05234086 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.